Vancouver's 'compassion club' founders fight drug laws after trafficking conviction
Vancouver's 'compassion club' founders fight drug laws after trafficking conviction
Vancouver's 'compassion club' founders fight drug laws after trafficking conviction
The founders of Vancouver's Drug User Liberation Front (DULF) are awaiting the outcome of a constitutional challenge after being convicted of drug trafficking. The club, which ran from August 2022 to October 2023, aimed to reduce overdoses by testing and supplying safer substances to its members.
Jeremy Kalicum, one of the co-founders, recently testified in B.C. Supreme Court as part of the legal fight against Canada's drug laws.
DULF operated with funding from Vancouver Coastal Health to provide drug-checking and overdose prevention services. The group planned to test illicit substances and distribute high-purity alternatives to members, but strict regulations blocked them from working with pharmaceutical suppliers.
Instead, the club bought drugs using donations and sold them at cost to members. Frustrated by Health Canada's slow response, Kalicum claimed the agency showed little urgency in engaging with their proposals. This led DULF to source substances from the dark web, where they could obtain purer versions of heroin, cocaine, and methamphetamine.
The constitutional challenge now argues that a section of the Controlled Drugs and Substances Act is unconstitutional. DULF claims its enforcement causes harm by preventing harm-reduction efforts. Kalicum has also accused media attention and institutional neglect of contributing to the founders' arrests, stating they were 'thrown under the bus' by multiple organisations.
No updates have emerged on public debates in Canada about legalising or regulating similar 'compassion clubs' since DULF's closure last October.
The court's decision will determine whether DULF's approach could be legally recognised as a harm-reduction measure. For now, the founders remain convicted but are awaiting the challenge's outcome. Their case highlights ongoing tensions between drug policy enforcement and overdose prevention efforts in Canada.